A scientific morning about Eplerenone safety over Spironolactone according to the latest Heart failure Guidelines and articles was held on Monday, May 29, 1402, at Chamran Hospital in Isfahan.
In this meeting, the bioequivalence studies conducted on Leprenzo medicine were also discussed, which is bioequivalent with its originator.
Shahid Madani Tabriz Heart Center morning meeting was held on july 23, 1400 on the role of Ticagrelor. in the treatment of Acute Coronary Syndrome and presentation of clinical studies. This meeting was held in the presence of respected professors, including: Interventionist: Dr.Separham, Dr.Ghaffari Dr.Aslan Abadi Dr.Sohrabi Electrophysiologist: Dr.Abbas Nezhad
Holding the scientific program of Tehran Heart Center Cath Conference with lecture of Dr. Rahimi, (Kimiara Company’ Medical Science Liaison), on the role of Ticagloror molecule in the treatment of Acute Coronary Syndrome and review of clinical studies on Thursday, July 24, 1400. In this scientific meeting: The superior properties
A scientific morning session on the new strategy in pain management with high-dose ibuprofen and also addressing osteoporosis with a new form of calcium supplement was held on Saturday, May 18, 2024, in Tajrish Hospital. In this session, Dr. Rahimi, the medical advisor of the company, presented the prevalence of
Kimiaara Pharmaceutical Company was established in 2005 as one of the subsidiaries of Ahran Tejarat Group.
Address : 2nd Floor, No. 27, Sharifi St., North Gandhi Ave., Tehran, Iran
All rights of this website belong to Kimiaara Pharmaceutical Company. © 2024
